5‐Fluorouracil treatment represses pseudouridine‐containing miRNA export into extracellular vesicles.

Autor: Qu, Shimian, Nelson, Hannah M., Liu, Xiao, Wang, Yu, Semler, Elizabeth M., Michell, Danielle L., Massick, Clark, Franklin, Jeffrey L., Karijolich, John, Weaver, Alissa M., Coffey, Robert J., Liu, Qi, Vickers, Kasey C., Patton, James G.
Předmět:
Zdroj: Journal of Extracellular Biology; Sep2024, Vol. 3 Issue 9, p1-14, 14p
Abstrakt: 5‐Fluorouracil (5‐FU) has been used for chemotherapy for colorectal and other cancers for over 50 years. The prevailing view of its mechanism of action is inhibition of thymidine synthase leading to defects in DNA replication and repair. However, 5‐FU is also incorporated into RNA causing defects in RNA metabolism, inhibition of pseudouridine modification, and altered ribosome function. We examined the impact of 5‐FU on post‐transcriptional small RNA modifications (PTxMs) and the expression and export of RNA into small extracellular vesicles (sEVs). EVs are secreted by all cells and contain a variety of proteins and RNAs that can function in cell‐cell communication. We found that treatment of colorectal cancer (CRC) cells with 5‐FU represses sEV export of miRNA and snRNA‐derived RNAs, but promotes export of snoRNA‐derived RNAs. Strikingly, 5‐FU treatment significantly decreased the levels of pseudouridine on both cellular and sEV small RNA profiles. In contrast, 5‐FU exposure led to increased levels of cellular small RNAs containing a variety of methyl‐modified bases. These unexpected findings show that 5‐FU exposure leads to altered RNA expression, base modification, and aberrant trafficking and localization of small RNAs. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje